First identified as a metastasis suppressor in melanoma (thus the name “kisspeptin” from Kiss-1) [109], kisspeptin exerts an antimetastatic action in some cancers (brain, lung, colon), but in BC this peptide promotes aggressiveness and aggravates BC prognosis [110]. The gene discussed is KISS1; the disease is breast cancer.